497 related articles for article (PubMed ID: 24776520)
1. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children.
Olarte L; Hulten KG; Lamberth L; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2014 Oct; 33(10):1033-6. PubMed ID: 24776520
[TBL] [Abstract][Full Text] [Related]
2. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis.
McNeil JC; Hulten KG; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2009 Sep; 28(9):766-8. PubMed ID: 19636285
[TBL] [Abstract][Full Text] [Related]
3. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
4. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
5. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
6. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
Kaplan SL; Barson WJ; Lin PL; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
Pediatr Infect Dis J; 2013 Mar; 32(3):203-7. PubMed ID: 23558320
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
9. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
[TBL] [Abstract][Full Text] [Related]
10. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal serotypes causing acute otitis media among children in Barcelona (1992-2011): emergence of the multiresistant clone ST320 of serotype 19A.
Gene A; del Amo E; Iñigo M; Monsonis M; Pallares R; Muñoz-Almagro C
Pediatr Infect Dis J; 2013 Apr; 32(4):e128-33. PubMed ID: 23190779
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines.
Koutouzis EI; Michos A; Koutouzi FI; Chatzichristou P; Parpounas K; Georgaki A; Theodoridou M; Tsakris A; Syriopoulou VP
Pediatr Infect Dis J; 2016 Mar; 35(3):292-6. PubMed ID: 26569193
[TBL] [Abstract][Full Text] [Related]
13. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
Kaur R; Casey JR; Pichichero ME
Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806
[TBL] [Abstract][Full Text] [Related]
14. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
Charfi F; Smaoui H; Kechrid A
Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
[TBL] [Abstract][Full Text] [Related]
15. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era.
Kaplan SL; Center KJ; Barson WJ; Ling-Lin P; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Peters TR; Gurtman A; Scott DA; Trammel J; Gruber WC; Hulten KG; Mason EO
Clin Infect Dis; 2015 May; 60(9):1339-45. PubMed ID: 25648240
[TBL] [Abstract][Full Text] [Related]
16. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010.
Cho EY; Lee H; Choi EH; Kim YJ; Eun BW; Cho YK; Kim YK; Jo DS; Lee HS; Lee J; Kim MN; Kim DS; Lee HJ
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):481-6. PubMed ID: 24529940
[TBL] [Abstract][Full Text] [Related]
17. Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.
Bruce MG; Singleton R; Bulkow L; Rudolph K; Zulz T; Gounder P; Hurlburt D; Bruden D; Hennessy T
Vaccine; 2015 Sep; 33(38):4813-9. PubMed ID: 26247901
[TBL] [Abstract][Full Text] [Related]
18. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM
Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates.
Ozawa D; Yano H; Endo S; Hidaka H; Kakuta R; Okitsu N; Kanamori H; Ogawa M; Ichimura S; Shimojima M; Inomata S; Kaku M; Katori Y
Pediatr Infect Dis J; 2015 Sep; 34(9):e217-21. PubMed ID: 26083590
[TBL] [Abstract][Full Text] [Related]
20. Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco).
Elmdaghri N; Benbachir M; Belabbes H; Zaki B; Benzaid H
Vaccine; 2012 Dec; 30 Suppl 6():G46-50. PubMed ID: 23228358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]